Skip to main content
. 2021 Apr 30;13(9):2160. doi: 10.3390/cancers13092160

Figure 4.

Figure 4

Prognostic role of TERT factors in the outcome of HCC after transarterial chemoembolization (TACE). Overall survival (OS) and time to progression (TTP) according to (A,B) the status of TERT promoter mutations, (C,D) the expression level of TERT, and (E,F) telomere length (TL).